Longitudinal analysis of circulating tumor DNA and CA19-9 dynamics in predicting disease relapse and monitoring treatment response in stage I–III pancreatic ductal adenocarcinoma: An interim analysis of a prospective observational study
European Journal of Cancer · 2026-10 · 247 · 117042
DOI: 10.1016/j.ejca.2026.117042 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Cancer, 2026-10. Verfasst von Siyi Zou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shangha…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, CA-19-9 Antigen, Carcinoma, Pancreatic Ductal, Circulating Tumor DNA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Science and Technology Major Project, National Natural Science Foundation of China, National Health Commission of the People's Republic of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Pancreatic Neoplasms Translational Research, Resea…
- Genecast (Wuhan) Precision Diagnostic Co., Ltd, Wuhan, China.
- Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine…
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Förderung
- National Science and Technology Major Project
- National Natural Science Foundation of China
- National Health Commission of the People's Republic of China
Zitieren
APA
Zou, S., Li, F., Xu, L. D., Zhang, J., Qian, J., Tian, Q., Liu, D., Jiang, C., Shen, B., Wen, C., & Zhan, Q. (2026). Longitudinal analysis of circulating tumor DNA and CA19-9 dynamics in predicting disease relapse and monitoring treatment response in stage I–III pancreatic ductal adenocarcinoma: An interim analysis of a prospective observational study. European Journal of Cancer, 247, 117042. https://doi.org/10.1016/j.ejca.2026.117042
Vancouver
Zou S, Li F, Xu LD, Zhang J, Qian J, Tian Q, et al. Longitudinal analysis of circulating tumor DNA and CA19-9 dynamics in predicting disease relapse and monitoring treatment response in stage I–III pancreatic ductal adenocarcinoma: An interim analysis of a prospective observational study. European Journal of Cancer. 2026;247:117042. doi:10.1016/j.ejca.2026.117042
BibTeX
@article{Zou2026,
author = {Zou, Siyi and Li, Fanlu and Xu, Li-Di and Zhang, Jiao and Qian, Juanjuan and Tian, Qiang and Liu, Di and Jiang, Cen and Shen, Baiyong and Wen, Chenlei and Zhan, Qian},
title = {Longitudinal analysis of circulating tumor DNA and CA19-9 dynamics in predicting disease relapse and monitoring treatment response in stage I–III pancreatic ductal adenocarcinoma: An interim analysis of a prospective observational study},
journal = {European Journal of Cancer},
year = {2026},
volume = {247},
pages = {117042},
doi = {10.1016/j.ejca.2026.117042}
}
EUVIMED